Literature DB >> 9554337

The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease.

R Peeker1, F Aldenborg, M Fall.   

Abstract

PURPOSE: Interstitial cystitis is a chronic debilitating condition that mainly affects women. Accumulated evidence indicates that interstitial cystitis is a heterogeneous syndrome. The nonulcer type seems to respond less favorably to various conservative treatments than the classic type. Supratrigonal cystectomy with ileocystoplasty is established treatment for interstitial cystitis refractory to conservative treatment. We evaluate whether classic interstitial cystitis responds differently than nonulcer disease to subtotal bladder resection and ileocystoplasty.
MATERIALS AND METHODS: We evaluated 13 patients 27 to 79 years old with interstitial cystitis who underwent supratrigonal cystectomy and ileocystoplasty due to failure to respond to conservative treatment.
RESULTS: In all 10 patients with classic interstitial cystitis symptoms were relieved after ileocystoplasty. In the 3 patients with nonulcer interstitial cystitis pain remained, while the frequency of voiding somewhat decreased. In these patients trigonal resection and urinary diversion with a Kock pouch resolved the symptoms.
CONCLUSIONS: Our study confirms that supratrigonal cystectomy with ileocystoplasty results in a good outcome in classic interstitial cystitis. However, this method seems to be unsuitable for nonulcer disease. Identification of the relevant subtype of interstitial cystitis is of crucial importance for selecting the appropriate method of lower urinary tract reconstruction.

Entities:  

Mesh:

Year:  1998        PMID: 9554337     DOI: 10.1097/00005392-199805000-00018

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Functional and chronic anorectal and pelvic pain disorders.

Authors:  Adil E Bharucha; Emanuel Trabuco
Journal:  Gastroenterol Clin North Am       Date:  2008-09       Impact factor: 3.806

Review 2.  Idiopathic cystitis in domestic cats--beyond the lower urinary tract.

Authors:  C A T Buffington
Journal:  J Vet Intern Med       Date:  2011-05-12       Impact factor: 3.333

Review 3.  [Interstitial cystitis : Diagnosis and pharmacological and surgical therapy].

Authors:  A Gonsior; J Neuhaus; L C Horn; T Bschleipfer; J-U Stolzenburg
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

Review 4.  Global concepts of bladder pain syndrome (interstitial cystitis).

Authors:  Jørgen Nordling; Magnus Fall; Philip Hanno
Journal:  World J Urol       Date:  2011-11-05       Impact factor: 4.226

5.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

6.  The role of reconstructive surgery in patients with end-stage interstitial cystitis/bladder pain syndrome: is cystectomy necessary?

Authors:  Elaine J Redmond; Hugh D Flood
Journal:  Int Urogynecol J       Date:  2017-03-11       Impact factor: 2.894

7.  Advances in diagnosis and treatment of interstitial cystitis/painful bladder syndrome.

Authors:  Avinash Chennamsetty; Michael J Ehlert; Kenneth M Peters; Kim A Killinger
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

Review 8.  Anorectal and Pelvic Pain.

Authors:  Adil E Bharucha; Tae Hee Lee
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

9.  Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes?

Authors:  Kim A Killinger; Judith A Boura; Kenneth M Peters
Journal:  Int Urogynecol J       Date:  2012-12-04       Impact factor: 2.894

10.  Retubularization of the ileocystoplasty patch for conversion into an ileal conduit.

Authors:  Peter A Massaro; Jerzy B Gajewski; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.